Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gonococcal arthritis

E Cucurull1, L R Espinoza

  • 1Section of Rheumatology, Louisiana State University Medical Center, New Orleans, USA.

Rheumatic Diseases Clinics of North America
|June 2, 1998
PubMed
Summary
This summary is machine-generated.

Disseminated gonococcal infection, a complication of gonorrhea, can cause septic arthritis. Monitoring antibiotic resistance is crucial for effective treatment as gonorrhea rates decline in some regions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.

Arthritis and rheumatism·2010
Same author

Gout in latin america.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Gouty arthritis mimicking rheumatoid arthritis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

A clinical profile of reactive arthritis in a peruvian series: a pilot study.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Fibromyalgia syndrome in young children: onset at age 10 years and younger.

Clinical and experimental rheumatology·2007
Same author

Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA).

Clinical rheumatology·2007
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Disseminated gonococcal infection (DGI) is the most frequent systemic complication of acute gonorrhea.
  • DGI affects 0.5% to 3.0% of individuals with untreated mucosal gonorrhea.
  • It is a leading cause of septic arthritis in individuals under 30 years old.

Purpose of the Study:

  • To summarize the epidemiology and clinical significance of disseminated gonococcal infection.
  • To highlight the importance of monitoring antibiotic resistance in Neisseria gonorrhoeae.

Main Methods:

  • Literature review on disseminated gonococcal infection and gonorrhea epidemiology.
  • Analysis of incidence rates and common complications.
  • Discussion of antimicrobial resistance trends.

Related Experiment Videos

Main Results:

  • Gonorrhea incidence is declining in the United States and Western Europe but remains high in developing nations.
  • Disseminated gonococcal infection is a significant cause of septic arthritis, particularly in younger populations.
  • Increasing antibiotic resistance necessitates ongoing surveillance.

Conclusions:

  • Effective management of gonorrhea and its complications relies on understanding epidemiological trends.
  • Continuous monitoring of antimicrobial susceptibilities is essential to guide treatment strategies for gonorrhea.
  • Public health efforts should focus on prevention and surveillance, especially in high-incidence areas.